Phase II Clinical Trial Scheme of Ganoderma Lucidum Spore Powder for Postoperative Chemotherapy of Osteosarcoma
Condition: Osteosarcoma Interventions: Drug: Ganoderma lucidum; Drug: Chemotherapy; Drug: Placebos Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bone Cancers | Chemotherapy | Clinical Trials | Ganoderma | Hospitals | Osteosarcoma | Research